- Release Date: 12/10/23 09:18
- Summary: Arovella licenses novel solid tumour targeting technology
- Price Sensitive: Yes
- Download Document 2.83MB
- Forums
- ASX - By Stock
- ALA
- Ann: Arovella licenses novel solid tumour targeting technology
ALA
arovella therapeutics limited
Add to My Watchlist
0.00%
!
9.5¢

Ann: Arovella licenses novel solid tumour targeting technology
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
9.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $112.4M |
Open | High | Low | Value | Volume |
9.5¢ | 9.5¢ | 9.1¢ | $42.57K | 456.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6290 | 9.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.5¢ | 103728 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6290 | 0.094 |
2 | 12374 | 0.093 |
1 | 10782 | 0.092 |
3 | 43805 | 0.091 |
1 | 25000 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.095 | 103728 | 2 |
0.096 | 105229 | 2 |
0.097 | 319890 | 2 |
0.099 | 259000 | 3 |
0.100 | 1096393 | 5 |
Last trade - 14.15pm 17/09/2025 (20 minute delay) ? |
Featured News
ALA (ASX) Chart |